Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Cdx Report Program: Heterogeneity Revealed in Current Reporting Practices for Hemato-Oncology Companion Diagnostic (CDx) Markers in Multiple Countries

Sabit Delic, PhD, Piers Blombery, MBBS, María José Calasanz, PhD, Devon S. Chabot-Richards, MD, Dolors Colomer, PhD, Matteo G Della Porta, MD, Paul A S Evans, PhD, Torsten Haferlach, MD, Joanne Mason, FRCPath, Jay L Patel, MD, William S. Stevenson, MBBS, PhD, Christian Thiede, MD, Maria Teresa Voso, MD, Jordan Clark

Blood (2019) 134 (Supplement_1): 5837.

https://doi.org/10.1182/blood-2019-128652

Published: 2019

Journal Articles

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Blood (2014) 124 (21): 825.

https://doi.org/10.1182/blood.V124.21.825.825

Published: 2014

Journal Articles

Diagnostic Application of Immunophenotypic Analysis of Erythroid Dysplasia in Myelodysplastic Syndromes. a Report on Behalf of the European Leukemianet-IMDS-Flow Cytometry Working Group

Theresia M Westers, PhD, Eline MP Cremers, MD, Uta Oelschlaegel, PhD, Ulrika Johansson, PhD, Peter Bettelheim, MD, Birgit Witte, PhD, Matteo G Della Porta, MD, Wolfgang Kern, MD, Arjan van de Loosdrecht, MDPhD

Blood (2014) 124 (21): 1914.

https://doi.org/10.1182/blood.V124.21.1914.1914

Published: 2014

Journal Articles

Somatic Mutations of ASXL1 , RUNX1 and SETBP1 Improve Prognostic Stratification of Patients with Chronic Myelomonocytic Leukemia

Chiara Elena, MD, Anna Gallì, PhD, Esperanza Such, PhD, Ulrich Germing, Ettore Rizzo, PhD, Jose Cervera, MD, Elisabetta Molteni, PhD, Esther Schuler, Ilaria Ambaglio, MD, Maria Lopez-Pavia, Silvia Zibellini, PhD, Andrea Kuendgen, MD, Erica Travaglino, Reyes Sancho-Tello, Matteo G Della Porta, MD, Ana Isabel Vicente, Guillermo F. Sanz, MD PhD, Luca Malcovati, MD, Mario Cazzola, MD

Blood (2014) 124 (21): 1915.

https://doi.org/10.1182/blood.V124.21.1915.1915

Published: 2014

Journal Articles

Association Between Gene Expression Profiles and Commonly Mutated Genes In The Hematopoietic Stem Cells Of Patients With Myelodysplastic Syndromes

Andrea Pellagatti, PhD, Moritz Gerstung, PhD, Elli Papaemmanuil, PhD, Luca Malcovati, MD, Aristoteles Giagounidis, MD, PhD, Matteo G Della Porta, MD, Martin Jadersten, MD, PhD, Amit Verma, MD, Paresh Vyas, MD, PhD, Sally Killick, MD, Eva Hellstrom-Lindberg, MD, Mario Cazzola, MD, Peter J. Campbell, PhD, Jacqueline Boultwood

Blood (2013) 122 (21): 2779.

https://doi.org/10.1182/blood.V122.21.2779.2779

Published: 2013

Journal Articles

Genetic Determinants Of Disease Phenotype In Myelodysplastic Syndromes

Ilaria Ambaglio, MD, Luca Malcovati, MD, Elli Papaemmanuil, PhD, Anna Gallì, PhD, Matteo G Della Porta, MD, Chiara Elena, MD, Marta Ubezio, MD, Elisa Bono, MD, Matteo C Da Vià, MD, Anna Cattaneo, MD, Erica Travaglino, Rosangela Invernizzi, MD, Peter J. Campbell, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 2755.

https://doi.org/10.1182/blood.V122.21.2755.2755

Published: 2013

Journal Articles

The Revised International Prognostic Scoring System (IPSS-R) Predicts Posttransplantation Outcome Of Patients With Myelodysplastic Syndrome Receiving Allogeneic Stem Cell Transplantation: A Basis For Clinical Decision Making

Matteo G Della Porta, MD, Emilio Paolo Alessandrino, MD, Andrea Bacigalupo, MD, Bernardino Allione, MD, Luca Malcovati, MD, Maria Teresa van Lint, MD, Massimo Bernardi, MD, Francesco Onida, MD, Alberto Bosi, MD, Anna Paola Iori, MD, Raffaella Cerretti, MD, Paola Marenco, MD, Pietro Pioltelli, MD, Emanuele Angelucci, MD, Rosi Oneto, Cristiana Pascutto, PhD, Mario Cazzola, MD, Alessandro Rambaldi, MD

Blood (2013) 122 (21): 2765.

https://doi.org/10.1182/blood.V122.21.2765.2765

Published: 2013

Journal Articles

Clinical and Molecular Features Of Myeloid Neoplasms Carrying SRSF2 Mutation

Chiara Elena, MD, Luca Malcovati, MD, Elli Papaemmanuil, PhD, Anna Gallì, PhD, Matteo G Della Porta, MD, Ilaria Ambaglio, MD, Marta Ubezio, MD, Matteo C Da Vià, MD, Elisa Bono, MD, Anna Cattaneo, MD, Erica Travaglino, Rosangela Invernizzi, MD, Peter J. Campbell, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 1532.

https://doi.org/10.1182/blood.V122.21.1532.1532

Published: 2013

Journal Articles

Erythroid Activity, Transfusion Iron Overload, and Hepcidin Levels in Patients with Myelodysplastic Syndrome

Luca Malcovati, MD, Matteo G Della Porta, MD, Coby M Laarakkers, MD, Anna Gallì, BSc, Riccardo Albertini, MD, Margherita Maffioli, MD, Ilaria Ambaglio, MD, Erica Travaglino, Rosangela Invernizzi, MD, Remigio Moratti, MD, Dorine W. Swinkels, MD, PhD, Mario Cazzola, MD

Blood (2008) 112 (11): 2676.

https://doi.org/10.1182/blood.V112.11.2676.2676

Published: 2008

Journal Articles

Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS

Matteo G Della Porta, MD, Andrea Kuendgen, MD, Luca Malcovati, MD, Esther Zipperer, MD, Cristiana Pascutto, PhD, Erica Travaglino, Margherita Maffioli, MD, Ilaria Ambaglio, MD, Rosangela Invernizzi, MD, Ulrich Germing, MD, Mario Cazzola, MD

Blood (2008) 112 (11): 2677.

https://doi.org/10.1182/blood.V112.11.2677.2677

Published: 2008

Journal Articles

WHO Classification and WPSS Score Predict Post-Transplant Outcome in Adults with Myelodysplastic Syndrome: A Retrospective Study by GITMO - Gruppo Italiano Trapianto Midollo Osseo.

Paolo E. Alessandrino, MD, Matteo G. Della Porta, MD, Andrea Bacigalupo, MD, Maria Teresa Van Lint, MD, Michele Falda, MD, Francesco Onida, MD, Massimo Bernardi, MD, Anna P. Iori, MD, Alessandro Rambaldi, MD, Raffaella Cerretti, MD, Paola Marenco, MD, Pietro Pioltelli, MD, Cristiana Pascutto, PhD, Rosi Oneto, BS, Renato Fanin, MD, Alberto Bosi, MD

Blood (2007) 110 (11): 1466.

https://doi.org/10.1182/blood.V110.11.1466.1466

Published: 2007

Journal Articles

Granulocyte JAK2 (V617F) Mutation Status in Myeloid Neoplasms with Ringed Sideroblasts.

Luca Malcovati, MD, Matteo G. Della Porta, MD, Daniela Pietra, Anna Galli, Erica Travaglino, Elisa Rumi, MD, Rosangela Invernizzi, MD, Francesco Passamonti, MD, Mario Lazzarino, MD, Mario Cazzola, MD

Blood (2006) 108 (11): 854.

https://doi.org/10.1182/blood.V108.11.854.854

Published: 2006

Journal Articles

Immunophenotypic, Cytogenetic and Functional Characterization of Circulating Endothelial Cells in Myelodysplastic Syndromes.

Matteo G. Della Porta, MD, Luca Malcovati, MD, Gian Matteo Rigolin, MD, Vittorio Rosti, MD, Erica Travaglino, Emanuela Boveri, MD, Anna Galli, Sabrina Boggi, Rosangela Invernizzi, MD, Mario Cazzola, MD

Blood (2006) 108 (11): 850.

https://doi.org/10.1182/blood.V108.11.850.850

Published: 2006

Journal Articles

A WHO Classification-Based Prognostic Scoring System (WPSS) for Predicting Survival in Myelodysplastic Syndromes.

Luca Malcovati, MD, Ulrich Germing, MD, Andrea Kuendgen, MD, Matteo G. Della Porta, MD, Rosangela Invernizzi, MD, Aristoteles Giagounidis, MD, Barbara Hildebrandt, PhD, Paolo Bernasconi, MD, Sabine Knipp, MD, Mario Lazzarino, MD, Corinna Strupp, MD, Mario Cazzola, MD

Blood (2005) 106 (11): 788.

https://doi.org/10.1182/blood.V106.11.788.788

Published: 2005

Journal Articles

Evidence of Polyclonal Hematopoiesis in a Large Proportion of Patients with Low-Risk Myelodysplastic Syndrome.

Luca Malcovati, MD, Matteo G. Della Porta, MD, Anna Galli, BS, Sabrina Boggi, BS, Lucia Malabarba, MD, Daniela Pietra, BS, Francesco Passamonti, MD, Gaetano Bergamaschi, MD, Mario Lazzarino, MD, Mario Cazzola, MD

Blood (2004) 104 (11): 2364.

https://doi.org/10.1182/blood.V104.11.2364.2364

Published: 2004

Journal Articles

Flow Cytometry Evaluation of Erythroid Dysplasia in Patients with Myelodysplastic Syndrome.

Matteo G. Della Porta, MD, Luca Malcovati, MD, Erica Travaglino, Rosangela Invernizzi, MD, Mario Lazzarino, MD, Sonia Levi, BS, Paolo Arosio, PhD, Mario Cazzola, MD

Blood (2004) 104 (11): 2365.

https://doi.org/10.1182/blood.V104.11.2365.2365

Published: 2004

Journal Articles

Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to the WHO Criteria. A Basis for Clinical Decision-Making.

Luca Malcovati, MD, Matteo G. Della Porta, MD, Cristiana Pascutto, BS, Lucia Malabarba, MD, Erica Travaglino, Francesco Passamonti, MD, Rosangela Invernizzi, MD, Mario Lazzarino, MD, Mario Cazzola, MD

Blood (2004) 104 (11): 1430.

https://doi.org/10.1182/blood.V104.11.1430.1430

Published: 2004

NARROW

Cdx Report Program: Heterogeneity Revealed in Current Reporting Practices for Hemato-Oncology Companion Diagnostic (CDx) Markers in Multiple Countries

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Diagnostic Application of Immunophenotypic Analysis of Erythroid Dysplasia in Myelodysplastic Syndromes. a Report on Behalf of the European Leukemianet-IMDS-Flow Cytometry Working Group

Somatic Mutations of ASXL1 , RUNX1 and SETBP1 Improve Prognostic Stratification of Patients with Chronic Myelomonocytic Leukemia

Association Between Gene Expression Profiles and Commonly Mutated Genes In The Hematopoietic Stem Cells Of Patients With Myelodysplastic Syndromes

Genetic Determinants Of Disease Phenotype In Myelodysplastic Syndromes

The Revised International Prognostic Scoring System (IPSS-R) Predicts Posttransplantation Outcome Of Patients With Myelodysplastic Syndrome Receiving Allogeneic Stem Cell Transplantation: A Basis For Clinical Decision Making

Clinical and Molecular Features Of Myeloid Neoplasms Carrying SRSF2 Mutation

Erythroid Activity, Transfusion Iron Overload, and Hepcidin Levels in Patients with Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS

WHO Classification and WPSS Score Predict Post-Transplant Outcome in Adults with Myelodysplastic Syndrome: A Retrospective Study by GITMO - Gruppo Italiano Trapianto Midollo Osseo.

Granulocyte JAK2 (V617F) Mutation Status in Myeloid Neoplasms with Ringed Sideroblasts.

Immunophenotypic, Cytogenetic and Functional Characterization of Circulating Endothelial Cells in Myelodysplastic Syndromes.

A WHO Classification-Based Prognostic Scoring System (WPSS) for Predicting Survival in Myelodysplastic Syndromes.

Evidence of Polyclonal Hematopoiesis in a Large Proportion of Patients with Low-Risk Myelodysplastic Syndrome.

Flow Cytometry Evaluation of Erythroid Dysplasia in Patients with Myelodysplastic Syndrome.

Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to the WHO Criteria. A Basis for Clinical Decision-Making.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only